Dr. Joshua Daniel Gutierrez, MD

Dr. Gutierrez practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Gutierrez's NPI, 1821414913, was assigned on March 13, 2014. Dr. Gutierrez holds Oregon license MD214339.

Dr. Gutierrez's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Gutierrez's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Gutierrez to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gutierrez practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Gutierrez's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Gutierrez is licensed in Oregon.

CMS data shows 14 Medicare services from Dr. Gutierrez across 1 procedure code in 2024, for 18 Medicare patients. Medicare paid $1,900 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Gutierrez in 2024. 72% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gutierrez's median patient age at 53, with 54% women.

In 2024, Dr. Gutierrez wrote 27 Medicare Part D claims for 21 patients. 93% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Gutierrez for performance year 2024, reported as part of a group. Dr. Gutierrez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Gutierrez from 5 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $162.